01/01/2023: Radio Free Europe, Mass Extinction, Obesity
60 Minutes
00:00
Type 2 Diabetes
The vast majority of people with obesity simply can't afford wagovi and most insurance companies refuse to cover it. Partly because as A-HIP, the Health Insurance Trade Association explained in a statement, these drugs have not yet been proven to work well for long term weight management. Novo Nordisk also makes a drug for type 2 diabetes called ozempic which most insurers and employers do cover. There are about 110 million Americans eligible for an anti-obesity medication making it a costly investment for insurance.
Transcript
Play full episode
